Xiangliang Yang

31.2k citations
510 papers · 25.5k indexed · 11 hit papers · h-index 85
Topics
Nanoplatforms for cancer theranostics (158 papers)Nanoparticle-Based Drug Delivery (120 papers)Advanced Drug Delivery Systems (37 papers)

In The Last Decade

Xiangliang Yang

498 papers receiving 25.0k citations

Hit Papers

Tumor exosome-based n...199920262008201720192021199920102019200400600

Peers

Xiangliang Yang
Comparison fields: 5 of 175
  • Biomedical Engineering 11.4k
  • Molecular Biology 7.2k
  • Materials Chemistry 6.5k
  • Biomaterials 6.4k
  • Pharmaceutical Science 3.4k
Replace Prashant Kesharwani with:
Prashant Kesharwani India
Hélder A. Santos Finland
Véronique Préat Belgium
Zhirong Zhang China
Lin Mei China
Jong Oh Kim South Korea
Zhiyong Qian China
Abolfazl Akbarzadeh Iran
Qiang Zhang China
Chao Wang China
Xiangliang Yang relative to Prashant Kesharwani India Prashant Kesharwani's profile →
Citations per field
00.5×2.7×
Prashant Kesharwani · 1×
Citations per year

Countries citing papers authored by Xiangliang Yang

Since Specialization
Citations

This map shows the geographic impact of Xiangliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangliang Yang more than expected).

Fields of papers citing papers by Xiangliang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangliang Yang. The network helps show where Xiangliang Yang may publish in the future.

Co-authorship network of co-authors of Xiangliang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangliang Yang. A scholar is included among the top collaborators of Xiangliang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangliang Yang. Xiangliang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 1
4 3
5 2
6 6
7 1
8 3
9 2
10 15
11 26
12 23
13 19
14 10
15 21
16 1
17 15
18 94
19 2
20
Involvement of TGF-β and ROS in G1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Under UVA Irradiation in a 3D Spheroid Model
1

About Xiangliang Yang

Xiangliang Yang is a scholar working on Biomaterials, Pharmaceutical Science and Biomedical Engineering, having authored 510 papers that have together received 25.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (158 papers), Nanoparticle-Based Drug Delivery (120 papers) and Advanced Drug Delivery Systems (37 papers). The work is most often cited by research in Pharmaceutical Science (3.4k citations), Biomaterials (6.4k citations) and Biomedical Engineering (11.4k citations). Xiangliang Yang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Huibi Xu, Huabing Chen, Lu Gan, Zifu Li, Jun Hu, Tuying Yong, Yanbing Zhao, Chen Xiao, Yongan Tang and Jiangling Wan. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026